| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |